These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 27508859)

  • 61. Development of immunostimulatory virotherapy using non-transmissible Sendai virus-activated dendritic cells.
    Yoneyama Y; Ueda Y; Akutsu Y; Matsunaga A; Shimada H; Kato T; Kubota-Akizawa M; Okano S; Shibata S; Sueishi K; Hasegawa M; Ochiai T; Yonemitsu Y
    Biochem Biophys Res Commun; 2007 Mar; 355(1):129-35. PubMed ID: 17292867
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Membrane Perturbation-Associated Ca2+ Signaling and Incoming Genome Sensing Are Required for the Host Response to Low-Level Enveloped Virus Particle Entry.
    Hare DN; Collins SE; Mukherjee S; Loo YM; Gale M; Janssen LJ; Mossman KL
    J Virol; 2015 Dec; 90(6):3018-27. PubMed ID: 26719279
    [TBL] [Abstract][Full Text] [Related]  

  • 63. IFN-λ4 Attenuates Antiviral Responses by Enhancing Negative Regulation of IFN Signaling.
    Obajemu AA; Rao N; Dilley KA; Vargas JM; Sheikh F; Donnelly RP; Shabman RS; Meissner EG; Prokunina-Olsson L; Onabajo OO
    J Immunol; 2017 Dec; 199(11):3808-3820. PubMed ID: 29070670
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A; Di Bisceglie AM; Ray RB
    J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
    [TBL] [Abstract][Full Text] [Related]  

  • 65. First-in-Human Evaluation of the Safety and Immunogenicity of an Intranasally Administered Replication-Competent Sendai Virus-Vectored HIV Type 1 Gag Vaccine: Induction of Potent T-Cell or Antibody Responses in Prime-Boost Regimens.
    Nyombayire J; Anzala O; Gazzard B; Karita E; Bergin P; Hayes P; Kopycinski J; Omosa-Manyonyi G; Jackson A; Bizimana J; Farah B; Sayeed E; Parks CL; Inoue M; Hironaka T; Hara H; Shu T; Matano T; Dally L; Barin B; Park H; Gilmour J; Lombardo A; Excler JL; Fast P; Laufer DS; Cox JH;
    J Infect Dis; 2017 Jan; 215(1):95-104. PubMed ID: 28077588
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization and signaling pathway analysis of interferon-kappa in bovine.
    Guo Y; An D; Liu Y; Bao J; Luo X; Cheng X; Wang Y; Gao M; Wang J
    Dev Comp Immunol; 2017 Feb; 67():213-220. PubMed ID: 27693540
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Induction and evasion of the type I interferon response by cytomegaloviruses.
    DeFilippis VR
    Adv Exp Med Biol; 2007; 598():309-24. PubMed ID: 17892221
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Paramyxovirus accessory proteins as interferon antagonists.
    Gotoh B; Komatsu T; Takeuchi K; Yokoo J
    Microbiol Immunol; 2001; 45(12):787-800. PubMed ID: 11838896
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Defective viral genomes arising in vivo provide critical danger signals for the triggering of lung antiviral immunity.
    Tapia K; Kim WK; Sun Y; Mercado-López X; Dunay E; Wise M; Adu M; López CB
    PLoS Pathog; 2013 Oct; 9(10):e1003703. PubMed ID: 24204261
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Reduced inflammation and altered innate response in neonates during paramyxoviral infection.
    Bhattacharya S; Beal BT; Janowski AM; Shornick LP
    Virol J; 2011 Dec; 8():549. PubMed ID: 22185352
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Lipid droplet density alters the early innate immune response to viral infection.
    Monson EA; Crosse KM; Das M; Helbig KJ
    PLoS One; 2018; 13(1):e0190597. PubMed ID: 29293661
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Loss of Sendai virus C protein leads to accumulation of RIG-I immunostimulatory defective interfering RNA.
    Sánchez-Aparicio MT; Garcin D; Rice CM; Kolakofsky D; García-Sastre A; Baum A
    J Gen Virol; 2017 Jun; 98(6):1282-1293. PubMed ID: 28631605
    [TBL] [Abstract][Full Text] [Related]  

  • 73. IRF-3 activation by Sendai virus infection is required for cellular apoptosis and avoidance of persistence.
    Peters K; Chattopadhyay S; Sen GC
    J Virol; 2008 Apr; 82(7):3500-8. PubMed ID: 18216110
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Identification of key genes and signaling pathways during Sendai virus infection in vitro.
    Wei W; Kong W
    Braz J Microbiol; 2019 Jan; 50(1):13-22. PubMed ID: 30637656
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ambisense sendai viruses are inherently unstable but are useful to study viral RNA synthesis.
    Le Mercier P; Garcin D; Hausmann S; Kolakofsky D
    J Virol; 2002 Jun; 76(11):5492-502. PubMed ID: 11991977
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A bioassay for interferon type I based on inhibition of Sendai virus growth.
    Perler L; Pfister H; Schweizer M; Peterhans E; Jungi TW
    J Immunol Methods; 1999 Jan; 222(1-2):189-96. PubMed ID: 10022385
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Differential invasion by Sendai virus of abdominal parenchymal organs and brain tissues in cortisone- and cyclophosphamide-based immunosuppressed mice.
    Miyamae T
    J Vet Med Sci; 2005 Apr; 67(4):369-77. PubMed ID: 15876786
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Host specificity of the anti-interferon and anti-apoptosis activities of parainfluenza virus P/C gene products.
    Chambers R; Takimoto T
    J Gen Virol; 2009 Aug; 90(Pt 8):1906-1915. PubMed ID: 19423549
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Early Growth Response Gene-1 Suppresses Foot-and-Mouth Disease Virus Replication by Enhancing Type I Interferon Pathway Signal Transduction.
    Zhu Z; Du X; Li P; Zhang X; Yang F; Cao W; Tian H; Zhang K; Liu X; Zheng H
    Front Microbiol; 2018; 9():2326. PubMed ID: 30319594
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Mice deficient in NKLAM have attenuated inflammatory cytokine production in a Sendai virus pneumonia model.
    Lawrence DW; Shornick LP; Kornbluth J
    PLoS One; 2019; 14(9):e0222802. PubMed ID: 31539400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.